Tanhaji, Hajina A.

HRN: 14-25-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/28/2024
04/25/2024
TIV
500mg
Q8
AMOEBIASIS
Checking Final Appropriateness 
03/29/2024
CEFTRIAXONE 1G (VIAL)
03/29/2024
04/05/2024
IV
OD
2g
UTI
Checking Final Appropriateness 
04/01/2024
METRONIDAZOLE 500MG (TAB)
04/01/2024
04/07/2024
PO
750mg
TID
Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: